
11 - 50 employees
Founded 2021
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
💰 Seed Round on 2023-02
Healthcare • Consulting • Manufacturing
Rarity Bioscience is a biotechnology company founded in 2021 as a spin-out from Uppsala University, focused on developing and commercializing the superRCA® assay technology. This innovative technology enables ultrasensitive detection of rare nucleic acid sequences in liquid biopsy and tissue samples, facilitating advanced mutation detection crucial for cancer diagnostics. With its proprietary assays, Rarity Bioscience aims to enhance testing accessibility and efficiency, employing well-established flow cytometry methods for rapid and reliable results.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 2 hours ago
Customer Success Manager driving adoption and sales growth for Rarity Bioscience’s molecular diagnostics. Supporting laboratories through onboarding, training, technical application support, and account expansion across the US.
🇺🇸 United States – Remote
💰 Seed Round on 2023-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
🏆 Customer Success
👻 Ghost score 15%